Mei Qin, M.D., Ph.D.
Scientific Review Officer, Office of Scientific Review
Mei Qin, M.D., Ph.D., commenced her role as a scientific review officer (SRO) at the National Center for Complementary and Integrative Health (NCCIH) in January 2024. As part of the Office of Scientific Review, she coordinates the scientific review of applications submitted to NCCIH under various funding programs. Dr. Qin received her M.D. from Harbin Medical University and Ph.D. in pediatrics and neuroscience from Shanghai Medical University, China. Her doctoral research focused on developing early therapeutic strategies for brain injury in infants suffering from hypoxic ischemic encephalopathy. Prior to her current position at NCCIH, Dr. Qin was an SRO in the Center for Scientific Review, contributing to the AN-Q(55) Recurring PAR Panel: Research on Current Topics in Alzheimer’s Disease and Its Related Dementias within the Aging and Neurodegeneration Review Branch of the Division of Neuroscience, Development, and Aging. Her earlier career includes significant roles in the intramural programs of both the National Institute of Mental Health (NIMH) and the National Institute on Drug Abuse. Initially joining as a postdoctoral fellow, she later advanced to the position of staff scientist. During this tenure, Dr. Qin's research was centered on uncovering the mechanisms behind neurodevelopmental disorders (e.g., Fragile X syndrome and autism) and developing modified treatments. Her investigative methods included behavioral assays, neuroimaging, measuring brain protein metabolism, and studying neuronal signal transduction.